US pharmaceutical giant Baxter Healthcare has renewed its commitment to the RegTracker software system now owned by Synapse Partnership, following the recent acquisition from Phase Forward
US pharmaceutical giant Baxter Healthcare has renewed its
commitment to the RegTracker software system now owned by Synapse
Partnership, following the recent acquisition from Phase Forward.
Invaluable to regulatory affairs specialists, the global
registration management tool keeps track of information and
activities surrounding marketing authorisations for
phwrmaceuticals throughout the product lifecycle.
Healthcare is a global health care company, which, through its
subsidiaries, provides critical therapies for people with
"We have deployed RegTracker to
more than 100 users across three company divisions in 17
countries throughout the EEC.
Each division is responsible for
their own data, but the project management module of RegTracker
offers European headquarters a complete overview of any product
variation or approval status project," said Patrick Hoet,
European director of regulatory affairs at Baxter Healthcare.
"RegTracker has been used for four years throughout Europe.
As a result, we have now rolled RegTracker out to some of our US
operations to start managing our global registrations with the
same system." E-records and specialist pharmaceutical IT
systems supplier Synapse now holds responsibility for global
marketing, sales, installation, development, support and
maintenance of RegTracker.
Former Phase Forward employee Ola
Strandberg has joined the team to ensure continuity of customer
support, maintenance and development, and help facilitate a
smooth transition between the two companies.